Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective

Androgen receptor targeted therapies in metastatic castration-resistant prostate cancer – The urologists' perspective

Androgen deprivation therapy (ADT), which involves the maximal suppression of circulating testosterone, underpins the treatment approach to metastatic hormone sensitive prostate cancer. Although initial responses are generally favourable, approximately half of cases progress to metastatic castrate r...

Full description

Bibliographic Details
Main Authors: Jo-Lynn Tan, Niranjan Sathianathen, Nicolas Geurts, Rajesh Nair, Declan G. Murphy, Alastair D. Lamb
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-12-01
Series:Urological Science
Subjects:
Castration-resistant prostate cancer
Prostate cancer
Androgen receptor
Androgen synthesis inhibitor
Androgen deprivation therapy
Novel androgen receptor antagonist
Abiraterone
Enzalutamide
Online Access:http://www.sciencedirect.com/science/article/pii/S1879522617301069

Internet

http://www.sciencedirect.com/science/article/pii/S1879522617301069

Similar Items